Asarfi Hospital Ltd is Rated Buy

Current Rating Overview

MarketsMOJO currently assigns Asarfi Hospital Ltd a 'Buy' rating, reflecting a positive outlook on the stock’s potential for investors. This rating is supported by a Mojo Score of 74.0, indicating a solid investment case, albeit slightly lower than the previous 'Strong Buy' grade which had a score of 82. The change in rating and score was recorded on 11 May 2026, but it is important to note that all financial data and returns referenced here are as of 18 May 2026, ensuring the analysis is based on the latest available information.

Quality Assessment

Asarfi Hospital Ltd’s quality grade is assessed as average. This suggests that while the company maintains a stable operational foundation, there are areas where it could improve to reach higher quality benchmarks. The company demonstrates a strong ability to service its debt, with a Debt to EBITDA ratio of 1.96 times, which is considered healthy for a microcap hospital sector player. This manageable leverage reduces financial risk and supports sustainable growth.

Valuation Attractiveness

The valuation grade for Asarfi Hospital Ltd is very attractive, signalling that the stock is currently priced favourably relative to its earnings and growth prospects. The company’s Return on Capital Employed (ROCE) stands at 15.6%, which is a robust indicator of efficient capital utilisation. Additionally, the Enterprise Value to Capital Employed ratio is a low 3, further underscoring the stock’s appealing valuation. The PEG ratio of 0.4 highlights that the stock’s price growth is modest compared to its earnings growth, making it an enticing option for value-conscious investors.

Financial Trend and Performance

Currently, the company’s financial metrics indicate strong growth momentum. As of 18 May 2026, Asarfi Hospital Ltd has delivered a remarkable 79.42% return over the past year, with a year-to-date gain of 1.44%. The latest data shows net sales growing at an annual rate of 27.70%, while operating profit has expanded even faster at 34.16%. The company has reported positive results for four consecutive quarters, with the latest six months’ Profit After Tax (PAT) at ₹9.34 crores, reflecting a growth rate of 48.96%. Net sales for the same period reached ₹91.34 crores, growing at 34.34%. Furthermore, the operating profit to interest coverage ratio is notably high at 10.87 times, indicating strong earnings relative to interest expenses.

Technical Outlook

The technical grade for Asarfi Hospital Ltd is bullish, suggesting that the stock’s price momentum and chart patterns are favourable. Despite a one-day decline of 2.33% and a one-week drop of 23.51%, the stock has rebounded with a three-month gain of 8.63%. This volatility is typical for microcap stocks but the overall trend remains positive, supported by solid fundamentals and investor interest. The stock’s six-month return is slightly negative at -6.56%, but the strong one-year performance and recent quarterly results provide confidence in its upward trajectory.

Investor Implications

For investors, the 'Buy' rating on Asarfi Hospital Ltd indicates a favourable risk-reward profile. The company’s very attractive valuation combined with positive financial trends and a bullish technical outlook suggests that the stock has potential for capital appreciation. However, the average quality grade advises a degree of caution, signalling that investors should monitor operational metrics and sector developments closely. The microcap status of the company also implies higher volatility and liquidity considerations, which should be factored into investment decisions.

Company Profile and Shareholding

Asarfi Hospital Ltd operates within the hospital sector and is classified as a microcap company. The majority shareholding is held by promoters, which often aligns management interests with those of shareholders. The company’s consistent growth in net sales and profits, alongside its ability to service debt comfortably, positions it well within its sector despite the challenges faced by smaller healthcare providers.

Summary of Key Metrics

As of 18 May 2026, Asarfi Hospital Ltd’s stock returns and financial indicators present a compelling picture. The stock’s one-year return of 79.42% significantly outpaces many peers in the hospital sector, reflecting strong investor confidence. The company’s net sales and operating profit growth rates of 27.70% and 34.16% respectively, demonstrate robust operational expansion. The low Debt to EBITDA ratio of 1.96 times and high interest coverage ratio of 10.87 times further reinforce the company’s financial stability. These factors collectively justify the current 'Buy' rating, signalling that the stock remains an attractive option for investors seeking growth in the healthcare space.

Outlook and Considerations

Looking ahead, investors should consider the evolving healthcare landscape and regulatory environment, which can impact hospital sector companies. While Asarfi Hospital Ltd’s fundamentals are strong, the average quality grade suggests that operational efficiencies and competitive positioning should be monitored. The very attractive valuation offers a margin of safety, but market volatility inherent to microcap stocks requires a measured approach. The bullish technical signals provide additional confidence in the stock’s near-term price momentum.

Conclusion

In conclusion, Asarfi Hospital Ltd’s current 'Buy' rating by MarketsMOJO reflects a balanced assessment of its quality, valuation, financial trend, and technical outlook. The rating update on 11 May 2026 set the tone, but the comprehensive analysis as of 18 May 2026 confirms the stock’s appeal for investors seeking exposure to a growing hospital sector player with strong financials and attractive valuation metrics. While not without risks, the company’s growth trajectory and market performance make it a noteworthy candidate for inclusion in a diversified portfolio.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today